Molecular Signature of miR-34a/NEAT-1/p53 Axis in Mycosis Fungoides

被引:0
|
作者
Fares, Reham [1 ]
Elasmer, Shimaa M. [2 ]
Khalefa, Abeer A. [3 ]
Shaker, Olfat G. [4 ]
El-Tahlawi, Samar M. [5 ]
Sabri, Ahmed [6 ]
Yaseen, Sara M. [7 ]
机构
[1] Fayoum Univ, Fac Med, Dept Med Biochem & Mol Biol, Faiyum, Egypt
[2] Fayoum Univ, Fac Med, Dept Clin & Chem Pathol, Al Fayyum, Egypt
[3] Zagazig Univ, Fac Med, Dept Physiol, Zagazig, Egypt
[4] Cairo Univ, Fac Med, Dept Med Biochem & Mol Biol, Cairo, Egypt
[5] Cairo Univ, Fac Med, Dept Dermatol, Cairo, Egypt
[6] Fayoum Gen Hosp, Al Fayyum, Egypt
[7] Fayoum Univ, Fac Med, Dept Dermatol STDs & Androl, Al Fayyum, Egypt
关键词
NONCODING RNA NEAT1; MICRORNA EXPRESSION; P53;
D O I
10.1155/2024/3163839
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background. Mycosis fungoides (MF) is a type of cutaneous T-cell lymphoma where red rash exists on the skin. Understanding the role of miRNAs and ncRNAs in p53-response has become an open discussion, as they can regulate p53 or its downstream targets, and ncRNAs themselves. Objectives. To evaluate the serum levels of NEAT-1, miR-34a, and p53 in MF patients and its relation to healthy controls to indicate whether it has a potential role in the pathogenesis of the disease. Subjects and Methods. This prospective case-control study was carried out on 75 subjects subdivided into two groups, 35 MF patients (stages 1 and II) and 40 matched healthy controls. Their clinical investigations and serum biomarkers (NEAT-1, miR-34a, and p53) were measured. Results. There were significant elevations in the expression levels of both NEAT-1 (5.10 +/- 1.16) and p53 (277.28 +/- 62.02) in the serum of MF patients in comparison with controls (1.01 +/- 0.031) and (194.29 +/- 16.039), respectively, while the level of miR-34a tends to decrease in MF patients (0.24 +/- 0.15). There are no significant difference between MF stages and the level of miR-34a, while in NEAT-1 and p53, there are significant differences with p value <0.05 between the stages and the biomarkers. There is a positive correlation between the %BSA and miR-34a and a slightly positive correlation between NEAT-1 and P53 with (r = 0.353, p = 0.037) and (r = 0112, p = 0.05), respectively. There were also negative correlations between disease duration and NEAT-1 with (r = -0.341, p = 0.045) and between B2 microglobulin level and p53 (r = -0.373, p = 0.027). Conclusion. The combination of miR-34a, NEAT-1, and p53 may be considered as potential biomarkers that play an active role in the disease process of MF for helping in its early diagnosis and stage identification as well.
引用
收藏
页数:8
相关论文
共 50 条
  • [31] miR-34a directly targets the MAGE-A family to positively modulate p53 and confer chemosensitivity in medulloblastoma
    Weeraratne, Shyamal
    Cho, Yoon-Jay
    Amani, Vladimir
    Neiss, Adrianne
    Pomeroy, Scott
    CANCER RESEARCH, 2009, 69
  • [32] miR-34a, miR-29c and miR-17-5p expression in chronic lymphocytic leukemia patients is dependent on p53 functionality
    Mraz, Marek
    Kotaskova, Jana
    Malinova, Karla
    Pavlova, Sarka
    Tichy, Boris
    Malcikova, Jitka
    Trbusek, Martin
    Mayer, Jiri
    Pospisilova, Sarka
    CANCER RESEARCH, 2009, 69
  • [33] MiR-34, SIRT1 and p53 The feedback loop
    Yamakuchi, Munekazu
    Lowenstein, Charles J.
    CELL CYCLE, 2009, 8 (05) : 712 - 715
  • [34] The tumor suppressor axis p53/miR-34a regulates Axl expression in B-cell chronic lymphocytic leukemia: implications for therapy in p53-defective CLL patients
    Boysen, J.
    Sinha, S.
    Price-Troska, T.
    Warner, S. L.
    Bearss, D. J.
    Viswanatha, D.
    Shanafelt, T. D.
    Kay, N. E.
    Ghosh, A. K.
    LEUKEMIA, 2014, 28 (02) : 451 - 455
  • [35] The tumor suppressor axis p53/miR-34a regulates Axl expression in B-cell chronic lymphocytic leukemia: implications for therapy in p53-defective CLL patients
    J Boysen
    S Sinha
    T Price-Troska
    S L Warner
    D J Bearss
    D Viswanatha
    T D Shanafelt
    N E Kay
    A K Ghosh
    Leukemia, 2014, 28 : 451 - 455
  • [36] PDL1 Regulation by p53 via miR-34
    Cortez, Maria Angelica
    Ivan, Cristina
    Valdecanas, David
    Wang, Xiaohong
    Peltier, Heidi J.
    Ye, Yuping
    Araujo, Luiz
    Carbone, David P.
    Shilo, Konstantin
    Giri, Dipak K.
    Kelnar, Kevin
    Martin, Desiree
    Komaki, Ritsuko
    Gomez, Daniel R.
    Krishnan, Sunil
    Calin, George A.
    Bader, Andreas G.
    Welsh, James W.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2016, 108 (01):
  • [37] Transcriptional activation of miR-34a contributes to p53-mediated apoptosis
    Raver-Shapira, Nina
    Marciano, Efi
    Meiri, Eti
    Spector, Yael
    Rosenfeld, Nitzan
    Moskovits, Neta
    Bentwich, Zvi
    Oren, Moshe
    MOLECULAR CELL, 2007, 26 (05) : 731 - 743
  • [38] miR-34a inhibits migration and invasion by regulating the SIRT1/p53 pathway in human SW480 cells
    Lai, Mingguang
    Du, Gang
    Shi, Ruiyue
    Yao, Jun
    Yang, Genhua
    Wei, Yue
    Zhang, Dingguo
    Xu, Zhenglei
    Zhang, Ru
    Li, Yingxue
    Li, Zicheng
    Wang, Lisheng
    MOLECULAR MEDICINE REPORTS, 2015, 11 (05) : 3301 - 3307
  • [39] miR-34a promotes liver fibrosis in patients with chronic hepatitis via mediating Sirt1/p53 signaling pathway
    Li, Xiaojie
    Zhang, Weiying
    Xu, Kun
    Lu, Jing
    PATHOLOGY RESEARCH AND PRACTICE, 2020, 216 (05)
  • [40] MiR-34a/Sirt1/p53 signaling pathway contributes to cadmium-induced nephrotoxicity: A preclinical study in mice*
    Hao, Rili
    Song, Xinyu
    Sun-Waterhouse, Dongxiao
    Tan, Xintong
    Li, Feng
    Li, Dapeng
    ENVIRONMENTAL POLLUTION, 2021, 282